Literature DB >> 8782735

Microalbuminuria in obese patients with or without hypertension.

P Valensi1, M Assayag, M Busby, J Pariès, B Lormeau, J R Attali.   

Abstract

OBJECTIVE: To evaluate the prevalence in obese patients of an increased urinary albumin excretion rate (UAER) and the factors involved in this parameter.
SUBJECTS: Two hundred and seven nondiabetic obese patients with BMI = 34.7 +/- 5.7 (SD) kg/m2. None had proteinuria or a history of nephropathy or uropathy. Fifty-two had moderate hypertension. A control group of 22 lean healthy subjects was also studied. MEASUREMENTS: The UAER was determined from 24-h urine samples by means of immunonephelemetry laser method. Creatinine clearance was calculated. Glycemia and plasma C peptide at fasting and 120 mine after glucose oral administration, HbA1c, serum fructosamine, plasma total cholesterol and triglycerides, HDL and LDL cholesterol were measured. Food intakes were determined by dietary history.
RESULTS: Compared with the control group, the UAER was significantly higher in the obese patients (18.0 +/- 20.1 mg/24 h vs 3.2 +/- 2.8 mg/24 h, P < 0.0001). It was elevated (> 30 mg/24 h) in 25 obese patients (12.1%) and in particular, in 19.2% of the obese patients with hypertension. It was significantly higher in the patients with android or mixed (both android and gynoid) obesity than in those with gynoid obesity (p = 0.050). Log UAER correlated negatively with the duration of hypertension (p = 0.038) and was higher in the patients with familial hypertension than in those without (p = 0.002). Log UAER correlated strongly with log creatinine clearance (p < 0.0001) and fractional albumin clearance (p < 0.0001). It correlated significantly with fasting and 120 min after glucose plasma C peptide concentrations (p = 0.018 and p = 0.046, respectively). Creatinine clearance was significantly higher in the patients with android or mixed obesity than in those with gynoid obesity (p = 0.001). Log creatinine clearance correlated negatively with age (p = 0.046), and log LDL cholesterol (p = 0.025) and positively with log lipid caloric intake (p = 0.014).
CONCLUSION: These results show the high prevalence of microalbuminuria in nondiabetic obese patients and suggest the involvement of renal hyperfiltration. Microalbuminuria may be an indicator of familial hypertension in obese subjects. Insulin resistance may be involved in the increase in the UAER. Nutritional factors, particularly lipid intake, may contribute to this increase in the UAER via an increase in glomerular hyperfiltration.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8782735

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  20 in total

1.  Managing weighty issues on lean evidence: the challenges of bariatric medicine.

Authors:  Arya M Sharma
Journal:  CMAJ       Date:  2005-01-04       Impact factor: 8.262

2.  Intra-abdominal fat and elevated urine albumin excretion in men with type 1 diabetes.

Authors:  Shalamar D Sibley; Ian H de Boer; Michael W Steffes; John D Brunzell
Journal:  Diabetes Care       Date:  2007-04-24       Impact factor: 19.112

3.  Prevalence of microalbuminuria among secondary school children.

Authors:  A N Okpere; I C Anochie; F U Eke
Journal:  Afr Health Sci       Date:  2012-06       Impact factor: 0.927

Review 4.  Adiponectin effects on the kidney.

Authors:  Natalie Sweiss; Kumar Sharma
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2013-09-05       Impact factor: 4.690

5.  Increased renal cellular senescence in murine high-fat diet: effect of the senolytic drug quercetin.

Authors:  Seo Rin Kim; Kai Jiang; Mikolaj Ogrodnik; Xiaojun Chen; Xiang-Yang Zhu; Hannah Lohmeier; Leena Ahmed; Hui Tang; Tamara Tchkonia; LaTonya J Hickson; James L Kirkland; Lilach O Lerman
Journal:  Transl Res       Date:  2019-07-15       Impact factor: 7.012

6.  Identifying the determinants of microalbuminuria in obese patients in primary care units: the effects of blood pressure, random plasma glucose and other risk factors.

Authors:  E Pehlivan; G Ozen; H Taskapan; G Gunes; I Sahin; C Colak
Journal:  J Endocrinol Invest       Date:  2015-06-21       Impact factor: 4.256

7.  Prevalence and risk factors of microalbuminuria in Thai nondiabetic hypertensive patients.

Authors:  Pongsathorn Gojaseni; Angkana Phaopha; Worawon Chailimpamontree; Thaweepong Pajareya; Anutra Chittinandana
Journal:  Vasc Health Risk Manag       Date:  2010-03-24

Review 8.  Challenges in the optimisation of post-operative pain management with opioids in obese patients: a literature review.

Authors:  C Lloret-Linares; A Lopes; X Declèves; A Serrie; S Mouly; J-F Bergmann; S Perrot
Journal:  Obes Surg       Date:  2013-09       Impact factor: 4.129

Review 9.  Obesity-related glomerulopathy: clinical and pathologic characteristics and pathogenesis.

Authors:  Vivette D D'Agati; Avry Chagnac; Aiko P J de Vries; Moshe Levi; Esteban Porrini; Michal Herman-Edelstein; Manuel Praga
Journal:  Nat Rev Nephrol       Date:  2016-06-06       Impact factor: 28.314

Review 10.  Optimizing blood pressure control in the obese patient.

Authors:  Tobias Pischon; Arya M Sharma
Journal:  Curr Hypertens Rep       Date:  2002-10       Impact factor: 5.369

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.